Is there evidence supporting the nephrotoxicity of sumatriptan in patients with migraine?
Year: 2026
Type: article
Abstract: No direct evidence for nephrotoxicity of sumatriptan in patients with migraine was identified. Limited human case reports suggest potential nephrotoxic risks, particularly in patients with compromised kidney function or using concurrent vasoactive drugs.
Author: Tripdatabase
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225987932
